drugset / Trial / NCT05252117

Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research.

NCT05252117

Phase 4 Unknown 240 enrolled Universidade do Vale do Sapucai
RandomizedParallel-groupSingle-blindTreatment

Summary

The use of intrauterine device (IUD) in Brazil is still not very significant and one of the reasons is the fear of feeling pain during its insertion procedure. Articaine is an amide-linked local anesthetic, its plasma half-life is shorter than that of most other amide-type anesthetics, which makes it theoretically favorable in relation to systemic toxicity.

Timeline

Start
2021-02-01
Primary completion
2022-04-30
Completion
2022-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Articaine Other / unclassified 1.8 ml Other
Subject Mepivacaine Other / unclassified 1.8 ml Other

Indications

No indication recorded.